- Home
- HYFM vs VYNE Comparison
HYFM vs VYNE Comparison
Compare HYFM & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYFM
- VYNE
- Stock Information
- Founded
- HYFM 1977
- VYNE 2003
- Country
- HYFM United States
- VYNE United States
- Employees
- HYFM N/A
- VYNE N/A
- Industry
- HYFM Industrial Machinery/Components
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- HYFM Industrials
- VYNE Health Care
- Exchange
- HYFM Nasdaq
- VYNE Nasdaq
- Market Cap
- HYFM 16.0M
- VYNE 16.0M
- IPO Year
- HYFM 2020
- VYNE 2018
- Fundamental
- Price
- HYFM $3.57
- VYNE $1.42
- Analyst Decision
- HYFM Hold
- VYNE Strong Buy
- Analyst Count
- HYFM 2
- VYNE 2
- Target Price
- HYFM $7.00
- VYNE $6.25
- AVG Volume (30 Days)
- HYFM 10.6K
- VYNE 964.9K
- Earning Date
- HYFM 08-07-2025
- VYNE 08-13-2025
- Dividend Yield
- HYFM N/A
- VYNE N/A
- EPS Growth
- HYFM N/A
- VYNE N/A
- EPS
- HYFM N/A
- VYNE N/A
- Revenue
- HYFM $176,650,000.00
- VYNE $605,000.00
- Revenue This Year
- HYFM $5.45
- VYNE $42.51
- Revenue Next Year
- HYFM $5.33
- VYNE N/A
- P/E Ratio
- HYFM N/A
- VYNE N/A
- Revenue Growth
- HYFM N/A
- VYNE 43.03
- 52 Week Low
- HYFM $1.50
- VYNE $0.85
- 52 Week High
- HYFM $8.55
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- HYFM 50.79
- VYNE 77.62
- Support Level
- HYFM $3.50
- VYNE $0.85
- Resistance Level
- HYFM $3.83
- VYNE $0.97
- Average True Range (ATR)
- HYFM 0.36
- VYNE 0.13
- MACD
- HYFM -0.01
- VYNE 0.08
- Stochastic Oscillator
- HYFM 36.28
- VYNE 85.56
About HYFM Hydrofarm Holdings Group Inc.
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.